Skip to main content
Sugentech, Inc. logo

Sugentech, Inc. — Investor Relations & Filings

Ticker · 253840 ISIN · KR7253840003 KO Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2023-05-02 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 253840

About Sugentech, Inc.

https://www.sugentech.com/en/

Sugentech, Inc. is an in-vitro diagnostics (IVD) company that develops and commercializes diagnostic solutions by integrating biotechnology, nanotechnology, and information technology. The company's product portfolio serves diverse healthcare settings, from large hospitals and laboratories to smaller clinics and home users. Key offerings include automated multi-immunoblot systems, point-of-care testing (POCT) platforms, and self-diagnostic kits for personal use, such as ovulation and pregnancy tests. Sugentech leverages proprietary technologies in developing high-level antibodies and advanced nanoparticles to create highly sensitive and precise immunochemical assays, underpinning its digital healthcare diagnostic platform for personalized medicine.

Recent filings

Filing Released Lang Actions
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to directors and employees, including the number of shares, exercise price, and legal basis. This type of disclosure regarding capital structure changes and equity-based compensation falls under the category of Regulatory Filings (RNS) as it is a specific corporate disclosure required by the regulator that does not fit into the other specialized categories like DIRS (which is for individual transactions) or SHA (which is for general share issuance).
2023-05-02 Korean
소속부변경
Regulatory Filings Classification · 100% confidence The document is a short regulatory notice regarding a change in the company's market classification (from 'Technology Growth' to 'Blue Chip' status) on the stock exchange. It does not fit into specific categories like financial reports, dividends, or M&A. As it is a standard regulatory announcement regarding company status, it falls under the RNS (Regulatory Filings) category.
2023-04-28 Korean
[기재정정]신규시설투자등
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Sugentech) regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes in investment amounts and construction plans. Since this is a specific regulatory announcement regarding capital expenditure and facility investment updates, and it does not fit into categories like M&A, Dividends, or Earnings, it falls under the 'Regulatory Filings' (RNS) category as a general corporate disclosure.
2023-04-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory requirement for insiders (directors/executives) to disclose their personal share transactions or changes in ownership. According to the provided definitions, this falls under 'Director's Dealing' (DIRS).
2023-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과). It details the outcomes of voting on agenda items such as financial statement approval, dividend declarations, director appointments, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2023-03-29 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Sugentech regarding the decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). This is a formal regulatory filing in Korea concerning the company's capital structure and share repurchase activities. Since it specifically details the company's decision to buy back its own shares through a trust, it falls under the 'Transaction in Own Shares' category.
2023-03-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.